Home » ISPE Announces 2012 FOYA Winners
ISPE Announces 2012 FOYA Winners
ISPE
01/24/2012
(TAMPA, FLORIDA USA, 24 January 2012) – The Facility of the Year Awards Judging Panel has named five Category Award Winners and selected one project for Special Recognition in the 2012 Facility of the Year Awards (FOYA) program. The winning projects for 2012 are located in Germany, India, Ireland, Italy, and the USA. The winning companies and respective award categories are:
Chiesi Farmaceutici S.p.A., winner of the Facility of the Year Award for Sustainability for its Chiesi Farmaceutici Research and Development Centre facility in Parma, Italy
Eisai Pharmatechnology & Manufacturing Pvt. Ltd., winner of the Facility of the Year Award for Project Execution for its Eisai Knowledge Centre facility in Visakhapatnam, Andhra Pradesh India
Merck & Co., Inc., winner of the Facility of the Year Award for Facility Integration for its Merck Vaccine Bulk Manufacturing Facility (VBF) Program of Projects in Durham, North Carolina USA
Rentschler Biotechnologie GmbH, winner of the Facility of the Year Award for Equipment Innovation for its REX III manufacturing facility in Laupheim, Germany
Roche Diagnostics GmbH, winner of the Facility of the Year Award for Operational Excellence for its TP Expand project in Penzberg, Germany
National Institute for Bioprocessing Research and Training (NIBRT), winner of the Facility of the Year Award Special Recognition for Novel Collaboration for its New Greenfield facility in Dublin, Ireland
The FOYA program is the pharmaceutical industry’s premier awards program dedicated to celebrating innovation and accomplishments in facility design, construction, and operation. The Facility of the Year Awards program recognizes state-of-the-art pharmaceutical manufacturing projects that utilize new and innovative technologies to enhance the delivery of a quality project, as well as reduce the cost of producing high-quality medicines. Now entering its ninth year, the awards program effectively spotlights the accomplishments, shared commitment, and dedication of individuals in companies worldwide to innovate and advance pharmaceutical manufacturing technology for the benefit of patients worldwide. The Facility of the Year Awards program is sponsored by ISPE, INTERPHEX, and Pharmaceutical Processing magazine.
“Our 2012 Category Winners reflect the true spirit of the Facility of the Year Awards program,” said Judging Panel Chairperson and upcoming “Lessons from 483s” conference keynote speaker Chaz Calitri. “The winning projects exemplify innovation in pharmaceutical manufacturing for the benefit of patients all over the world, who depend upon us for medications that are high quality, available and affordable. Our winners come from 5 different countries and include novel, low cost biologics facilities, creative and visionary industry-academia-government collaborations, and hyper-fast track investments made to ensure vaccine’s get to patients in need. We are also proud this year to recognize facilities that seek to speed up drug development as well as facilities that greatly reduce the environmental “footprint” of manufacturing in the communities in which they reside”
The Facility of the Year Awards program is truly global, as submissions over the past eight years have been received from more than 25 different countries and territories. Each of the submissions was reviewed by an independent, blue-ribbon judging panel consisting of global senior-level executives from all aspects of the industry. The judging panel met personally in December to select the Category Awards Winners and select the 2012 overall winner, which will be announced to the world for the first time at ISPE’s Annual Meeting in November.
2012 Facility of the Year Events
There will be several opportunities to learn first-hand about the facilities being honored as “best in their class.” These opportunities include:
INTERPHEX2012 – Attendees will be able to meet the Category Award Winners at the Facility of the Year Awards Display Area near the front of the exhibit hall of the Jacob K. Javits Convention Center in New York City, New York, USA. Team members from winning companies will be on-hand to discuss the success stories associated with these pharmaceutical manufacturing facilities. More information, including registration information, can be found at www.interphex.com.
ISPE 2012 Annual Meeting – Category Winners will give presentations about their winning projects during ISPE’s 2012 Annual Meeting, 11-14 November in San Francisco, California USA. The highly anticipated announcement of the 2012 Facility of the Year Awards Overall Winner will also take place during the Keynote Session of this event. Information and updates on this global event can be found at www.ISPE.org.
Comprehensive details about each of this year’s award-winning projects and their support teams, plus additional information on the awards program itself, can be found at www.FacilityoftheYear.org.
More News:
-
05/17/2012
Study: US Clears Drugs Faster Than Europe, CanadaFrom WSJ.com
Researchers say the U.S. approved more new medicines in less time than Europe and Canada in the last decade, challenging long-standing criticisms that the Food and Drug Administration lags behind its peers in clearing important new drugs.
-
05/10/2012
Ex-Sanofi Chemist Sentenced To 18 Months For Trade Secrets TheftFrom WSJ.com
A 30-year-old former research chemist for pharmaceutical firm Sanofi was sentenced to 18 months in prison for stealing Sanofi trade secrets and making them available through another company, the U.S. Department of Justice said.
-
04/27/2012
Novo Nordisk Expanding U.S. Workforce 15 Percent
Most new positions are in sales and management, but manufacturing jobs will be added in Clayton, N.C.
-
04/26/2012
AstraZeneca’s Brennan to Retire; Lowth Named Interim CEOFrom Bloomberg.com
AstraZeneca Chief Executive Officer David Brennan will retire from his post, ending a six- year tenure after repeated failures in drug development left investors skeptical of the company’s earnings prospects.
-
04/19/2012
Congress Pushing to Allow Generic Drug Manufacturers to Make Label ChangesFrom Pharmalot
The U.S. Congress has introduced bills that would allow generic makers to make updates to labels as new safety and efficacy information becomes available.
- 04/18/2012 GSK Shifts to Unassigned Seating in RTP Offices
- 04/17/2012 Amgen CEO Comes Clean: I Was Arrogant and an Awful Listener
- 04/16/2012 Product News: Growth Direct Systems for Environmental Monitoring and Sterility
-
04/12/2012
J&J Fined $1.2 Billion in Drug CaseFrom NYTimes.com
A judge in Arkansas ordered Johnson & Johnson and a subsidiary to pay more than $1.2 billion in fines on Wednesday, a day after a jury found that the companies had minimized or concealed the dangers associated with an antipsychotic drug.
- 04/11/2012 Humira Set to Become World's Top-Selling Drug
- All news »
Get Connected Now!
- Featured White Papers

Print page